|
Total 326 Docetaxel
Patents
(Data from US
Patent & Trademark Office)
No. 1
- 100 / 101-200
/ 201 - 300 / 301
- 326 /
No. 201 - 300 Docetaxel Patents:
|
PAT. NO. |
|
Title |
| 201 |
6,153,756 |
 |
Soluble
prodrugs of paclitaxel |
| 202 |
6,153,644 |
|
Stabilized
injectable pharmaceutical compositions containing taxoid anti-neoplastic
agents |
| 203 |
6,153,585 |
|
Arylsulfonanilide
derivatives |
| 204 |
6,153,212 |
|
Biodegradable
terephthalate polyester-poly (phosphonate) compositions, articles,
and methods of using the same |
| 205 |
6,147,082 |
|
Chalcones
having antiproliferative activity |
| 206 |
6,143,900 |
|
Stereoselective
synthesis of oxazoline derivative |
| 207 |
6,140,362 |
|
Method
for inhibiting the growth of mammalian cells |
| 208 |
6,136,990 |
|
Taxoid
compound and method for producing the same |
| 209 |
6,136,988 |
|
7-hexanoyltaxol
and methods for preparing the same |
| 210 |
6,136,835 |
|
Methods
of treatment for viral infections |
| 211 |
6,133,462 |
|
C-7
CBZ baccatin III and production method therefor |
| 212 |
6,129,757 |
|
Implantable
members for receiving therapeutically useful compositions |
| 213 |
6,127,555 |
|
Taxane
hydroxy monoacylation method |
| 214 |
6,127,390 |
|
Inhibitors
of prenyl-protein transferase |
| 215 |
6,124,482 |
|
Process
for isolation of 10-deacetyl baccatin-III |
| 216 |
6,121,278 |
|
Di-n-heterocyclic
compounds, methods, and compositions for inhibiting parp activity |
| 217 |
6,120,805 |
|
Microspheres,
process for their preparation and their use |
| 218 |
6,111,144 |
|
Method
for the synthesis of a taxane intermediate |
| 219 |
6,110,891 |
|
Lectin
compositions and uses thereof |
| 220 |
6,107,497 |
|
Intermediate
for use in docetaxel synthesis and production method therefor |
| 221 |
6,107,333 |
|
Parenteral
paclitaxel in a stable non-toxic formulation |
| 222 |
6,107,305 |
|
Use
of pyrazolo [3,4-b] pyridine as cyclin dependent kinase inhibitors |
| 223 |
6,107,034 |
|
GATA-3
expression in human breast carcinoma |
| 224 |
6,106,866 |
|
In
vivo agents comprising cationic drugs, peptides and metal chelators
with acidic saccharides and glycosaminoglycans, giving improved
site-selective localization, uptake mechanism, sensitivity and
kinetic-spatial profiles, including tumor sites |
| 225 |
6,103,698 |
|
Dolastatin-15
derivatives in combination with taxanes |
| 226 |
6,103,487 |
|
Method
of treating cancer |
| 227 |
6,100,411 |
|
Taxoid
anti-tumor agents and pharmaceutical compositions thereof |
| 228 |
6,099,563 |
|
Substrates,
particularly medical devices, provided with bio-active/biocompatible
coatings |
| 229 |
6,096,909 |
|
Taxoid
anti-tumor agents and pharmaceutical compositions thereof |
| 230 |
6,096,331 |
|
Methods
and compositions useful for administration of chemotherapeutic
agents |
| 231 |
6,087,350 |
|
Use
of pretreatment chemicals to enhance efficacy of cytotoxic agents |
| 232 |
6,080,877 |
|
Taxanes |
| 233 |
6,080,733 |
|
Thioureido-cyclodextrins,
utilized in particular to solubilize anti-tumor, and antiparasitic
agents and their preparation processes |
| 234 |
6,072,060 |
|
Synthesis
of taxol, taxol analogs and their intermediates with variable A-ring
side chain structures and compositions thereof |
| 235 |
6,071,952 |
|
Stabilized
injectable pharmaceutical compositions containing taxoid anti-neoplastic
agents |
| 236 |
6,071,947 |
|
Indolyl-pyrrolydenemethylpyrrole
derivatives and process for their preparation |
| 237 |
6,066,749 |
|
Method
for conversion of C-2'-O-protected-10-hydroxy taxol to
c-2'-O-protected taxol:useful intermediates in paclitaxel synthesis |
| 238 |
6,066,668 |
|
Formulations
and methods of reducing toxicity of antineoplastic agents |
| 239 |
6,066,645 |
|
Formulations
and methods of reducing toxicity of antineoplastic agents |
| 240 |
6,063,780 |
|
Method
of treating a tumor |
| 241 |
6,057,361 |
|
Formulations
and methods of reducing toxicity of antineoplastic agents |
| 242 |
6,048,990 |
|
Method
for selective acylation of C-2'-O-protected-10-hydroxy-taxol at the
C-10 position |
| 243 |
6,048,849 |
|
Formulations
and methods of reducing toxicity of antineoplastic agents |
| 244 |
6,048,847 |
|
Use
of betulinic acid and its derivatives for inhibiting cancer growth
and a method of monitoring this |
| 245 |
6,046,234 |
|
Formulations
and methods of reducing toxicity of antineoplastic agents |
| 246 |
6,046,159 |
|
Formulations
and methods of reducing toxicity of antineoplastic agents |
| 247 |
6,043,249 |
|
Formulations
and methods of reducing toxicity of antineoplastic agents |
| 248 |
6,040,466 |
|
Taxoids,
their preparation and pharmaceutical compositions containing them |
| 249 |
6,040,330 |
|
Pharmaceutical
formulations of taxanes |
| 250 |
6,040,321 |
|
Aminothiazole
inhibitors of cyclin dependent kinases |
| 251 |
6,040,312 |
 |
Formulations
and methods of reducing toxicity of antineoplastic agents |
| 252 |
6,040,304 |
|
Formulations
and methods of reducing toxicity of antineoplastic agents |
| 253 |
6,040,294 |
|
Formulations
and methods of reducing toxicity of antineoplastic agents |
| 254 |
6,037,454 |
|
Humanized
anti-CD11a antibodies |
| 255 |
6,030,941 |
|
Polymer
composition for delivering substances in living organisms |
| 256 |
6,028,164 |
|
Bioresorbable
compositions for implantable prostheses |
| 257 |
6,028,071 |
|
Purified
compositions of 10-propargyl-10-deazaaminopterin and methods of
using same in the treatment of tumors |
| 258 |
6,025,488 |
|
Formulations
and methods of reducing toxicity of antineoplastic agents |
| 259 |
6,020,507 |
|
Synthesis
of paclitaxel from baccatin III by protection of the 7-hydroxyl of
baccatin III using a strong base and an electrophile |
| 260 |
6,017,958 |
|
Method
of treating malignant tumors with thyroxine analogues having no
significant hormonal activity |
| 261 |
6,017,948 |
|
Water-miscible
pharmaceutical compositions |
| 262 |
6,017,935 |
|
7-sulfur
substituted paclitaxels |
| 263 |
6,013,646 |
|
Indolocarbazole
derivatives useful for the treatment of neurodegenerative diseases
and cancer |
| 264 |
6,008,318 |
|
Two-stage
solution polymerization of high molecular weight poly(phosphoesters) |
| 265 |
6,008,007 |
|
Radiation
resistance assay for predicting treatment response and clinical
outcome |
| 266 |
6,005,020 |
|
Bioresorbable
compositions for implantable prostheses |
| 267 |
6,002,024 |
|
Process
for the isolation of 14.beta.-hydroxy-10-deacetyl baccatin-III |
| 268 |
5,994,511 |
|
Anti-IgE
antibodies and methods of improving polypeptides |
| 269 |
5,994,409 |
|
Methods
for treatment of neuro--and nephro--disorders and therapeutic
toxicities using aminothiol compounds |
| 270 |
5,981,777 |
|
Recovery
of taxanes from plant material |
| 271 |
5,977,386 |
|
6-thio-substituted
paclitaxels |
| 272 |
5,977,163 |
|
Water
soluble paclitaxel prodrugs |
| 273 |
5,968,972 |
|
Method
for increasing the oral bioactivity of pharmaceutical agents |
| 274 |
5,965,739 |
|
.DELTA..sup.6,7
-taxols antineoplastic use and pharmaceutical compositions
containing them |
| 275 |
5,955,621 |
|
Recovery
of Taxanes from conifers |
| 276 |
5,955,489 |
|
Taxane
derivatives, the preparation thereof and formulations containing
them |
| 277 |
5,952,451 |
|
Solution
polymerization of high molecular weight poly(phosphoesters) in
toluene |
| 278 |
5,948,919 |
|
Paclitaxel
synthesis from precursor compounds and methods of producing the same |
| 279 |
5,939,566 |
|
Syntheses
of taxol, taxol analogs and their intermediates with variables
A-ring side chain structures and compositions thereof |
| 280 |
5,922,775 |
|
Method
of treating malignant tumors with ketone thyroxine analogues having
no significant hormonal activity |
| 281 |
5,919,816 |
|
Formulations
and methods of reducing toxicity of antineoplastic agents |
| 282 |
5,919,815 |
|
Taxane
compounds and compositions |
| 283 |
5,917,062 |
|
Intermediates
and methods useful in the semisynthesis of paclitaxel and analogs |
| 284 |
5,917,056 |
|
10-deacetyl-14.beta.-hydroxybaccactine
III derivatives, a process for the preparation thereof and
formulations containing them |
| 285 |
5,914,411 |
|
Alternate
method for acylating 10-deacetylbaccatin III selectively at the C-10
position |
| 286 |
5,912,264 |
|
6-halo-or
nitrate-substituted paclitaxels |
| 287 |
5,907,042 |
|
Intermediates
and methods useful in the semisynthesis of paclitaxel and analogs |
| 288 |
5,906,990 |
|
Taxoids,
preparation thereof, and pharmaceutical compositions containing same |
| 289 |
5,902,822 |
|
7-methylthiooxomethyl
and 7-methylthiodioxomethyl paclitaxels |
| 290 |
5,892,063 |
|
Cephalomannine
epoxide, its analogues and a method for preparing the same |
| 291 |
5,877,205 |
|
Parenteral
paclitaxel in a stable non-toxic formulation |
| 292 |
5,869,127 |
|
Method
of providing a substrate with a bio-active/biocompatible coating |
| 293 |
5,854,382 |
|
Bioresorbable
compositions for implantable prostheses |
| 294 |
5,840,929 |
|
C4
methoxy ether derivatives of paclitaxel |
| 295 |
5,821,363 |
|
Antineoplastic
use and pharmaceutical compositions containing them |
| 296 |
5,821,263 |
|
Sulfenamide
taxane derivatives |
| 297 |
5,811,452 |
|
Taxoid
reversal agents for drug-resistance in cancer chemotherapy and
pharmaceutical compositions thereof |
| 298 |
5,808,113 |
|
Preparation
of Taxol and docetaxel through primary amines |
| 299 |
5,795,909 |
|
DHA-pharmaceutical
agent conjugates of taxanes |
| 300 |
5,780,653 |
|
Nitrophenyl,
10-deacetylated substituted taxol derivatives as dual functional
cytotoxic/radiosensitizers |
No. 1
- 100 / 101-200
/ 201 - 300 / 301
- 326 /
|
